BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 22871684)

  • 1. Predictors and clinical features of postoperative hyperperfusion after surgical revascularization for moyamoya disease: a serial single photon emission CT/positron emission tomography study.
    Uchino H; Kuroda S; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2012 Oct; 43(10):2610-6. PubMed ID: 22871684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of focal cerebral hyperperfusion as a cause of transient neurologic deterioration after extracranial-intracranial bypass for moyamoya disease: comparative study with non-moyamoya patients using N-isopropyl-p-[(123)I]iodoamphetamine single-photon emission computed tomography.
    Fujimura M; Shimizu H; Inoue T; Mugikura S; Saito A; Tominaga T
    Neurosurgery; 2011 Apr; 68(4):957-64; discussion 964-5. PubMed ID: 21221039
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of prophylactic blood pressure lowering according to a standardized postoperative management protocol to prevent symptomatic cerebral hyperperfusion after direct revascularization surgery for moyamoya disease.
    Fujimura M; Inoue T; Shimizu H; Saito A; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2012; 33(5):436-45. PubMed ID: 22456617
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors for symptomatic cerebral hyperperfusion after superficial temporal artery-middle cerebral artery anastomosis in patients with moyamoya disease.
    Fujimura M; Mugikura S; Kaneta T; Shimizu H; Tominaga T
    Surg Neurol; 2009 Apr; 71(4):442-7. PubMed ID: 18514264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptomatic cerebral hyperperfusion on SPECT after indirect revascularization surgery for Moyamoya disease.
    Cho WS; Lee HY; Kang HS; Kim JE; Bang JS; Oh CW
    Clin Nucl Med; 2013 Jan; 38(1):44-6. PubMed ID: 23242046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. De novo ivy sign indicates postoperative hyperperfusion in moyamoya disease.
    Horie N; Morikawa M; Morofuji Y; Hiu T; Izumo T; Hayashi K; Nagata I
    Stroke; 2014 May; 45(5):1488-91. PubMed ID: 24713526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Crossed cerebellar diaschisis as an indicator of severe cerebral hyperperfusion after direct bypass for moyamoya disease.
    Uchino H; Kazumata K; Ito M; Nakayama N; Kuroda S; Houkin K
    Neurosurg Rev; 2021 Feb; 44(1):599-605. PubMed ID: 32076897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of early postoperative cerebral blood flow contributes to the prediction and diagnosis of cerebral hyperperfusion syndrome after revascularization surgery for moyamoya disease.
    Fujimura M; Niizuma K; Endo H; Sato K; Inoue T; Shimizu H; Tominaga T
    Neurol Res; 2015 Feb; 37(2):131-8. PubMed ID: 25082550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of Quantitative Cerebral Blood Flow Measurement in the Acute Stage after Revascularization Surgery for Adult Moyamoya Disease: Implication for the Pathological Threshold of Local Cerebral Hyperperfusion.
    Kameyama M; Fujimura M; Tashiro R; Sato K; Endo H; Niizuma K; Mugikura S; Tominaga T
    Cerebrovasc Dis; 2019; 48(3-6):217-225. PubMed ID: 31812964
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.
    Tashiro R; Fujimura M; Kameyama M; Mugikura S; Endo H; Takeuchi Y; Tomata Y; Niizuma K; Tominaga T
    Cerebrovasc Dis; 2019; 47(3-4):178-187. PubMed ID: 31121577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Moyamoya Disease: Region-Symptom Mapping and Estimating a Critical Threshold.
    Kazumata K; Uchino H; Tokairin K; Ito M; Shiga T; Osanai T; Kawabori M
    World Neurosurg; 2018 Jun; 114():e388-e395. PubMed ID: 29530706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Factors of Delayed Hyperperfusion and the Importance of Repeated Cerebral Blood Flow Evaluation for Hyperperfusion After Direct Bypass for Moyamoya Disease.
    Nomura S; Yamaguchi K; Ishikawa T; Kawashima A; Okada Y; Kawamata T
    World Neurosurg; 2018 Oct; 118():e468-e472. PubMed ID: 29990604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of Intraoperative Graft Flow Predicts Radiological Hyperperfusion during Bypass Surgery in Patients with Moyamoya Disease.
    Nakamura A; Kawashima A; Nomura S; Kawamata T
    Cerebrovasc Dis Extra; 2020; 10(2):66-75. PubMed ID: 32726777
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intraoperative assessment of cortical perfusion by indocyanine green videoangiography in surgical revascularization for moyamoya disease.
    Uchino H; Kazumata K; Ito M; Nakayama N; Kuroda S; Houkin K
    Acta Neurochir (Wien); 2014 Sep; 156(9):1753-60. PubMed ID: 24973201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective surgical revascularization improves cerebral hemodynamics and resolves headache in pediatric Moyamoya disease.
    Kawabori M; Kuroda S; Nakayama N; Hirata K; Shiga T; Houkin K; Tamaki N
    World Neurosurg; 2013 Nov; 80(5):612-9. PubMed ID: 23022638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between reduction in microvascular transit time after superficial temporal artery-middle cerebral artery bypass surgery for moyamoya disease and the development of postoperative hyperperfusion syndrome.
    Yang T; Higashino Y; Kataoka H; Hamano E; Maruyama D; Iihara K; Takahashi JC
    J Neurosurg; 2018 May; 128(5):1304-1310. PubMed ID: 28498060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Seizure following superficial temporal-middle cerebral artery anastomosis in patients with moyamoya disease: possible contribution of postoperative cerebral hyperperfusion].
    Narisawa A; Fujimura M; Shimizu H; Tominaga T
    No Shinkei Geka; 2007 May; 35(5):467-74. PubMed ID: 17491342
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of surgical revascularization on cerebral oxygen metabolism in patients with Moyamoya disease: an 15O-gas positron emission tomographic study.
    Kuroda S; Kashiwazaki D; Hirata K; Shiga T; Houkin K; Tamaki N
    Stroke; 2014 Sep; 45(9):2717-21. PubMed ID: 25116870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of the cortical hyperintensity belt sign in fluid-attenuated inversion recovery images after bypass surgery for moyamoya disease.
    Hamano E; Kataoka H; Morita N; Maruyama D; Satow T; Iihara K; Takahashi JC
    J Neurosurg; 2017 Jan; 126(1):1-7. PubMed ID: 26894456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnostic value of perfusion-weighted MRI for evaluating postoperative alteration of cerebral hemodynamics following STA-MCA anastomosis in patients with moyamoya disease].
    Fujimura M; Mugikura S; Shimizu H; Tominaga T
    No Shinkei Geka; 2006 Aug; 34(8):801-9. PubMed ID: 16910493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.